Literature DB >> 9765004

Clinical impact of lamivudine resistance in chronic hepatitis B.

P Honkoop, R A de Man, H G Niesters, S W Schalm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9765004     DOI： 10.1016/s0168-8278(98)80075-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  2 in total

Review 1.  Lamivudine. A review of its therapeutic potential in chronic hepatitis B.

Authors:  B Jarvis; D Faulds
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

2.  Cost-effectiveness analysis of lamivudine for the treatment of chronic hepatitis B.

Authors:  S J Crowley; D Tognarini; P V Desmond; M Lees
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.